After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
VIR belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Vir Biotechnology Inc is $844.49M. A total of 2.68 million shares were traded on the day, compared to an average of 1.41M shares.
In the most recent transaction, SVF Endurance (Cayman) Ltd sold 127,938 shares of VIR for 6.39 per share on Nov 26 ’25. After the transaction, the 10% Owner now owns 13,982,271 company shares. In a previous transaction on Nov 28 ’25, SVF Endurance (Cayman) Ltd sold 61,493 shares at 6.44 per share. VIR shares that 10% Owner owns now total 13,920,778.
Among the insiders who sold shares, SVF Endurance (Cayman) Ltd disposed of 235,971 shares on Nov 25 ’25 at a per-share price of $6.38. This resulted in the 10% Owner holding 14,110,209 shares of VIR after the transaction. In another insider transaction, SVF Endurance (Cayman) Ltd sold 227,803 shares at $6.15 per share on Nov 24 ’25. Company shares held by the 10% Owner now total 14,346,180.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, VIR has a high of $14.45 and a low of $4.16.
As of this writing, VIR has an earnings estimate of -$0.63 per share for the current quarter. EPS was calculated based on a consensus of 8.0 estimates, with a high estimate of -$0.16 per share and a lower estimate of -$0.76. The company reported an EPS of -$0.76 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. VIR’s latest balance sheet shows that the firm has $708.14M in Cash & Short Term Investments as of fiscal 2021. There were $137.49M in debt and $341.24M in liabilities at the time. Its Book Value Per Share was $5.73, while its Total Shareholder’s Equity was $1.43B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VIR is Buy with a score of 4.64.
